ValuEngine Upgrades Medicis Pharmaceutical To ‘5’ Rating

September 30, 2009 (FinancialWire) (Investrend Research Syndicate) — ValuEngine, Inc. has upgraded Medicis Pharmaceutical Corp (NYSE: MRX) to a “5″ rating, the service’s highest.

The ValuEngine Rating is an overall assessment of a stock’s attractiveness. It combines the following five factors: ValuEngine’s proprietary valuation, risk-return tradeoff, momentum, market capitalization and ValuEngine’s proprietary forecasted one-month return. Approximately 80 to 85 companies achieve this highest ValuEngine rating out of VE’s total coverage of over 5,000 publicly traded companies.

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, investment banks and broker-dealers. A special arrangement between the Investrend Research Syndicate and ValuEngine provides for preferred introductions and complimentary value-added services for those enrolling into ValuEngine programs. For more information write to valuengine@investrend.com. To receive ValuEngine research and commentary news alerts, write to firstalert@investrend.com with “ValuEngine” in the subject line.

The Investrend Research Syndicate, a proprietary entity of Investrend Communications, Inc., distributes equity research-related information issued by sources that deemed to be dedicated to unbiased, reliable and transparent analytics. The primary measure for vetting those sources is the “Standards for Independent Research Providers” as promulgated by the FIRST Research Consortium.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Powered by EIN Presswire